- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Syncom Formulations (India) Ltd (SYFI)
Syncom Formulations (India) Ltd stock price live, this page displays NSE SYFI stock exchange data. View the SYFI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Syncom Formulations (India) Ltd real time stock price chart below.
What Is the Syncom Formulations (India) Ltd Stock Price Today?
The Syncom Formulations (India) Ltd stock price today is 20.31.
What Is the Stock Symbol for Syncom Formulations (India) Ltd?
The stock symbol for Syncom Formulations (India) Ltd is "SYFI."
What Stock Exchange Does Syncom Formulations (India) Ltd Trade On?
Syncom Formulations (India) Ltd is listed and trades on the NSE stock exchange.
Is Syncom Formulations (India) Ltd a Good Stock to Buy?
Determining whether Syncom Formulations (India) Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYFI quote. (ISIN: INE312C01025)
What Is the Syncom Formulations (India) Ltd Stock Price Today?
The Syncom Formulations (India) Ltd stock price today is 20.31.
What Is the Stock Symbol for Syncom Formulations (India) Ltd?
The stock symbol for Syncom Formulations (India) Ltd is "SYFI."
What Stock Exchange Does Syncom Formulations (India) Ltd Trade On?
Syncom Formulations (India) Ltd is listed and trades on the NSE stock exchange.
Is Syncom Formulations (India) Ltd a Good Stock to Buy?
Determining whether Syncom Formulations (India) Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYFI quote. (ISIN: INE312C01025)
20.31
-0.06(-0.29%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.11
20.77
52 wk Range
10.21
27.49
SYNCOMF is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.1120.77
52 wk Range
10.2127.49
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SYNCOMF Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 11, 2026
EPS / Forecast
0.26 / --
Revenue / Forecast
1.26B / --
Compare SYNCOMF to Peers and Sector
Metrics to compare | SYNCOMF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYNCOMFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.4x | 28.2x | −0.2x | |
PEG Ratio | 1.30 | 0.51 | 0.00 | |
Price/Book | 4.6x | 3.0x | 2.6x | |
Price / LTM Sales | 3.8x | 3.1x | 2.8x | |
Upside (Analyst Target) | - | 11.7% | 60.5% | |
Fair Value Upside | Unlock | 0.2% | 7.8% | Unlock |
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, creams, liquids orals, and effervescent. Further, it provides liquid vials and ampoule injections, dry vial injections and inhalers; manufacturing and trading of nutraceuticals, dietary supplements, health supplements, functional foods, herbal and ayurvedic preparations, vitamins, minerals, proteins, antioxidants, natural extracts, organic and wellness products, and all related healthcare and nutrition-based goods and real estate business. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Syncom Formulations (SYNCOMF) Stock Price Today?
The Syncom Formulations stock price today is 20.31 INR.
What Stock Exchange Does Syncom Formulations Trade On?
Syncom Formulations is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Syncom Formulations?
The stock symbol for Syncom Formulations is "SYNCOMF."
Does Syncom Formulations Pay Dividends? What’s The Current Dividend Yield?
The Syncom Formulations dividend yield is 0.5%%.
What Is the Syncom Formulations Market Cap?
As of today, Syncom Formulations market cap is 19.01B INR.
What Is Syncom Formulations's Earnings Per Share (TTM)?
The Syncom Formulations EPS (TTM) is 0.90.
From a Technical Analysis Perspective, Is SYNCOMF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Syncom Formulations Stock Split?
Syncom Formulations has split 0 times.
How Many Employees Does Syncom Formulations Have?
Syncom Formulations has 902 employees.
What is the current trading status of Syncom Formulations (SYNCOMF)?
As of Nov 12, 2026, Syncom Formulations (SYNCOMF) is trading at a price of 20.31 INR, with a previous close of 20.37 INR. The stock has fluctuated within a day range of 20.11 INR to 20.77 INR, while its 52-week range spans from 10.21 INR to 27.49 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.